Madariaga L, Amurrio C, Martín G, García-Cebrian F, Bicandi J, Lardelli P, Suarez M D, Cisterna R
Department of Immunology, Microbiology and Parasitology, Basque Country University School of Medicine, Bilbao, Spain.
Int J Tuberc Lung Dis. 1998 Jan;2(1):62-8.
Among the cytokines involved in defensive mechanisms against Mycobacterium tuberculosis infection, special attention has been given to interferon-gamma (IFN-gamma); a local synthesis of this cytokine as well as IL-2 (type 1 cytokines) at the site of disease in patients with tuberculous pleuritis has been demonstrated. Moreover, high levels of IgG autoantibodies against IFN-gamma have been shown in several clinical situations. It has been suggested that these antibodies could serve to limit the intensity or duration of the immune response or be able to interfere with the pathophysiological effects of IFN-gamma.
To investigate the potential role of anti-IFN-gamma antibodies in the course of M. tuberculosis infection.
Investigation of the presence of these antibodies in sera from healthy and ill subjects infected with M. tuberculosis in relation to the extent of the disease and the presence of IFN-gamma in sera by enzyme-linked-immunosorbent assay (ELISA). In order to investigate the presence of these antibodies at the site of infection we included 12 pleural fluids from tuberculosis patients and 9 pleural fluids from other origins.
In the course of M. tuberculosis infection the production of anti-IFN-gamma IgG antibodies is induced, being particularly higher in healthy skin test converters. Among tuberculosis patients, the presence of anti-IFN-gamma autoantibodies is significantly associated with detectable levels of the cytokine in sera. Levels of anti-IFN-gamma antibodies in moderately advanced and far advanced tuberculosis patients are significantly greater than in healthy individuals. These antibodies increase at the site of infection.
Anti-IFN-gamma antibodies must be considered as a new element in the immune response to M. tuberculosis. It would be of great interest to investigate this point especially at the site of infection.
在参与抗结核分枝杆菌感染防御机制的细胞因子中,γ干扰素(IFN-γ)受到了特别关注;已证实在结核性胸膜炎患者的病灶部位,这种细胞因子以及白细胞介素-2(1型细胞因子)会进行局部合成。此外,在几种临床情况下,已发现针对IFN-γ的高水平IgG自身抗体。有人提出,这些抗体可能有助于限制免疫反应的强度或持续时间,或者能够干扰IFN-γ的病理生理效应。
研究抗IFN-γ抗体在结核分枝杆菌感染过程中的潜在作用。
通过酶联免疫吸附测定(ELISA),调查感染结核分枝杆菌的健康和患病受试者血清中这些抗体的存在情况,以及与疾病程度和血清中IFN-γ存在情况的关系。为了研究这些抗体在感染部位的存在情况,我们纳入了12份结核病患者的胸水和9份其他来源的胸水。
在结核分枝杆菌感染过程中,会诱导产生抗IFN-γ IgG抗体,在健康的结核菌素试验阳转者中尤其更高。在结核病患者中,抗IFN-γ自身抗体的存在与血清中可检测到的细胞因子水平显著相关。中度进展期和重度进展期结核病患者的抗IFN-γ抗体水平显著高于健康个体。这些抗体在感染部位增加。
抗IFN-γ抗体必须被视为抗结核分枝杆菌免疫反应中的一个新因素。尤其在感染部位研究这一点将非常有意义。